Our perspectives in one place
Topic
Selected filters
ClearNews
See allWHO Intergovernmental Negotiating Body (INB) intersessional briefing on “Access and benefit sharing”
On 22 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 10: WHO Pathogen Access and Benefit Sharing System, with the Pandemic Influenza Preparedness Framework as an example” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreWHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Sustainable and equitably distributed production”
On 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreWHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Transfer of technology and know-how”
On 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreWHO Intergovernmental Negotiating Body (INB) intersessional briefing on “One Health and the Quadripartite”
On 17 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 18: One Health and the Quadripartite” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreWHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Predictable global supply chain and logistics network”
On 17 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 6: Predictable global supply chain and logistics network” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreStatement at the Human Rights Council 52 Regular Session: Interactive dialogue on access to COVID-19 vaccines
On 17 March, IFPMA delivered a statement at the 52 Regular Session of the Human Rights Council (HRC) for the Interactive Dialogue with the Human Rights Commissioner on the report on Access to COVID-19 Vaccines.
Read morePublications
See allFee system for regional joint assessment procedures in Africa
This joint position paper covers the perspective from industry on the proposed fee system for regional joint assessment procedures in Africa.
Read more
Pharmacy-mediated substitution for biosimilars
This position paper from IFPMA addresses substitution relating to biosimilars and their reference products at the retail pharmacy level. While this practice has been in place in many countries for generics, for biosimilars, the practice is only emerging.
Read more
Convergence and reliance approaches for advanced therapy medicinal products
Cell, tissue and gene therapies offer significant potential to treat diseases with high unmet medical needs, and consist of human cell and tissue products for medical use and advanced therapy medicinal products (ATMPs). IFPMA shares points to consider when promoting regulatory convergence and reliance approaches for ATMPs.
Read more
Expert insights
See all
Stepping up research and innovation to beat TB
Read more
Five priorities for future pandemic preparedness and response
Read more
Five Priorities to Global Pandemic Preparedness
Read moreResources
See allCollaborating for Global Health Progress flyer
Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read more
Africa Youth Voices Summit: Activating youthful leadership toward the realization of universal health coverage
Ann-Lise Mikolajczak, Manager, Global Health and Access at IFPMA and Luca Deplano, Associate Manager, Innovation and Access Policy at IFPMA, joined Ryculture Health and Social Innovation’s 2nd Annual YouTH Voices Summit, focused on activating youthful leadership toward the realization of universal health coverage.
Read more
Impact of a waiver of intellectual property rights for COVID-19 therapeutics
As WTO Member States continue to discuss an extension of a waiver of intellectual property (IP) rights on COVID-19 therapeutics, latest evidence and data published today explains what the consequences of such a waiver would have on industry’s ability to fight the COVID-19 pandemic.
Read more